Artificial intelligence in pharmaceutical product formulation: Neural computing

The properties of a formulation are determined not only by the ratios in which the ingredients are combined but also by the processing conditions. Although the relationships between the ingredient levels, processing conditions, and product performance may be known anecdotally, they can rarely be quantified. In the past, formulators tended to use statistical techniques to model their formulations, relying on response surfaces to provide a mechanism for optimization. However, the optimization by such a method can be misleading, especially if the formulation is complex. More recently, advances in mathematics and computer science have led to the development of alternative modeling and data mining techniques which work with a wider range of data sources: neural networks (an attempt to mimic the processing of the human brain); genetic algorithms (an attempt to mimic the evolutionary process by which biological systems self-organize and adapt), and fuzzy logic (an attempt to mimic the ability of the human brain to draw conclusions and generate responses based on incomplete or imprecise information). In this review the current technology will be examined, as well as its application in pharmaceutical formulation and processing. The challenges, benefits and future possibilities of neural computing will be discussed. This article has been retracted. Link to the retraction 10.2298/CICEQ1104000E

[1]  P. York,et al.  Effect of varying optimization parameters on optimization by guided evolutionary simulated annealing (GESA) using a tablet film coat as an example formulation. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[2]  Rowe,et al.  Neuro-fuzzy logic in tablet film coating formulation. , 1999, Pharmaceutical science & technology today.

[3]  T Nagai,et al.  Formula optimization of theophylline controlled-release tablet based on artificial neural networks. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[4]  T Wu,et al.  Formulation Optimization Technique Based on Artificial Neural Network in Salbutamol Sulfate Osmotic Pump Tablets , 2000, Drug development and industrial pharmacy.

[5]  P ? ? ? ? ? ? ? % ? ? ? ? , 1991 .

[6]  Peter York,et al.  The effect of experimental design on the modeling of a tablet coating formulation using artificial neural networks. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[7]  Renata Jachowicz,et al.  Unified methodology of neural analysis in decision support systems built for pharmaceutical technology , 2007, Expert Syst. Appl..

[8]  G E Peck,et al.  Pharmaceutical granulation and tablet formulation using neural networks. , 1996, Pharmaceutical development and technology.

[9]  M C Meyer,et al.  The application of an artificial neural network and pharmacokinetic simulations in the design of controlled-release dosage forms. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[10]  M. Khan,et al.  Optimization and characterization of controlled release multi-particulate beads formulated with a customized cellulose acetate butyrate dispersion. , 2002, International journal of pharmaceutics.

[11]  John H. Holland,et al.  Adaptation in Natural and Artificial Systems: An Introductory Analysis with Applications to Biology, Control, and Artificial Intelligence , 1992 .

[12]  Franc Vrecer,et al.  Optimization of diclofenac sodium dissolution from sustained release formulations using an artificial neural network , 1997 .

[13]  Chee Peng Lim,et al.  Prediction of Drug Dissolution Profiles Using Artificial Neural Networks , 2001, Int. J. Comput. Intell. Appl..

[14]  Svetlana Ibrić,et al.  An investigation into the usefulness of generalized regression neural network analysis in the development of level A in vitro-in vivo correlation. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[15]  Chee Peng Lim,et al.  Application of a Recurrent Neural Network to Prediction of Drug Dissolution Profiles , 2002, Neural Computing & Applications.

[16]  H Schmidli,et al.  Advantages of Artificial Neural Networks (ANNs) as alternative modelling technique for data sets showing non-linear relationships using data from a galenical study on a solid dosage form. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[17]  Peter York,et al.  Comparison of neurofuzzy logic and neural networks in modelling experimental data of an immediate release tablet formulation. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[18]  Svetlana Ibrić,et al.  Generalized regression neural networks in prediction of drug stability , 2007, The Journal of pharmacy and pharmacology.

[19]  J. Parojčić,et al.  Artificial neural networks in the modeling and optimization of aspirin extended release tablets with eudragit L 100 as matrix substance , 2008, AAPS PharmSciTech.

[20]  John R. Koza,et al.  Genetic programming - on the programming of computers by means of natural selection , 1993, Complex adaptive systems.

[21]  Viness Pillay,et al.  Textural profiling and statistical optimization of crosslinked calcium-alginate-pectinate-cellulose acetophthalate gelisphere matrices. , 2002, Journal of pharmaceutical sciences.

[22]  Y. Bi,et al.  Preparation, evaluation and optimization of rapidly disintegrating tablets , 2002 .

[23]  J. Venitz,et al.  Comparison of Neural Network and Multiple Linear Regression as Dissolution Predictors# , 2003, Drug development and industrial pharmacy.

[24]  Kevin Martin Bossley,et al.  Neurofuzzy modelling approaches in system identification , 1997 .

[25]  William H. VerDuin Better Products Faster: A Practical Guide to Knowledge-Based Systems for Manufacturers , 1994 .

[26]  Raymond C. Rowe,et al.  Intelligent Software for Product Formulation , 1998 .

[27]  G. G. Stokes "J." , 1890, The New Yale Book of Quotations.

[28]  J Bourquin,et al.  Application of artificial neural networks (ANN) in the development of solid dosage forms. , 1997, Pharmaceutical development and technology.

[29]  Peter York,et al.  Optimisation of the predictive ability of artificial neural network (ANN) models: a comparison of three ANN programs and four classes of training algorithm. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[30]  J Bourquin,et al.  Comparison of artificial neural networks (ANN) with classical modelling techniques using different experimental designs and data from a galenical study on a solid dosage form. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[31]  Renata Jachowicz,et al.  Neural network as a decision support system in the development of pharmaceutical formulation - focus on solid dispersions , 2005, Expert Syst. Appl..

[32]  A. Shukla,et al.  Prediction of Drug Content and Hardness of Intact Tablets Using Artificial Neural Network and Near-Infrared Spectroscopy , 2001, Drug development and industrial pharmacy.

[33]  H Schmidli,et al.  Pitfalls of artificial neural networks (ANN) modelling technique for data sets containing outlier measurements using a study on mixture properties of a direct compressed dosage form. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[34]  G. Gauglitz,et al.  Optimization of crushing strength and disintegration time of a high-dose plant extract tablet by neural networks. , 1999, Drug development and industrial pharmacy.

[35]  A. Ghaffari,et al.  Performance comparison of neural network training algorithms in modeling of bimodal drug delivery. , 2006, International journal of pharmaceutics.

[36]  Svetlana Ibrić,et al.  The application of generalized regression neural network in the modeling and optimization of aspirin extended release tablets with Eudragit RS PO as matrix substance. , 2002, Journal of controlled release : official journal of the Controlled Release Society.